Abstract
To date, there has been no satisfactory explanation for the observation that interictal uptake of the glucose analog [18F]fluorodeoxyglucose (FDG) is consistently reduced in the temporal lobe ipsilateral to the seizure focus in patients with temporal lobe epilepsy. We examined the hypothesis that regional differences in tracer uptake in temporal lobe epilepsy reflect regional differences in the lumped constant (Λ). Methods: In 9 control subjects and 10 patients with temporal lobe epilepsy, we obtained regional estimates of Λ by expressing Λ in terms of transfer coefficients for FDG and parameters which are likely to remain constant throughout both the brain and under different functional states. Results: In the patients, Λ was lower in the temporal lobe ipsilateral to the epileptic focus (0.53 ± 0.06; p < 0.005) than in the contralateral temporal lobe (0.56 ± 0.06). Interside differences in Λ were highly correlated with asymmetry in tracer uptake. Furthermore, the use of regional estimates of Λ reduced the asymmetry in estimated rCMR(glc) in patients with temporal lobe epilepsy but not in controls. Conclusion: In these patients, a change in tracer uptake may not indicate a change in glucose consumption of corresponding magnitude, raising the possibility that in at least some patients with temporal lobe epilepsy, the term hypometabolism does not accurately describe reductions in tracer uptake.
Original language | English (US) |
---|---|
Pages (from-to) | 176-180 |
Number of pages | 5 |
Journal | Journal of Nuclear Medicine |
Volume | 39 |
Issue number | 1 |
State | Published - Jan 1 1998 |
Keywords
- Fluorine-18-fluorodeoxyglucose
- PET
- Temporal lobe epilepsy
ASJC Scopus subject areas
- Radiology Nuclear Medicine and imaging